Analysis of the Leading Players within the Drug Eluting Stents Market.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36906) has announced the addition of Drug Eluting Stents Technology & Market Forecasts to their offering The introduction of Drug Eluting Stents has dramatically impacted the market size and growth rates Growth Rates The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures. Notes: Remember, historically high growth rates don't always mean a high rate of growth looking into the future. for coronary stents worldwide. It has also impacted the distribution of market shares across the industry. The Drug Eluting Stent is the device of the moment. It promises to solve the main problem in interventional coronary management, restonosis. It is also becoming the only medical device to assume the status of a blockbuster drug A blockbuster drug is a drug generating more than $1 billion of revenue for its owner each year. The search for blockbusters has been the foundation of the R&D strategy adopted by big pharmaceutical companies, but this looks set to change. . The opportunity in Drug Eluting Stents is truly historic and is impacting the whole interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based supply chain. The coronary Drug Eluting Stents market is dynamic, highly competitive and is evolving fast. Drug Eluting Stents - Technology & Market Forecast is a New, 2006, is our best selling report. It provides a timely analysis of this market with profiles of leading participants and forecasts to the year 2010. With Drug Eluting Stents - Technology & Market Forecast, you'll be able to better: - Understand current market dynamics, competitors positions and market shares. - Assess market size and growth potential for these combined drug devices. - Monitor the competition's marketed and in-development products - Identify emerging technologies and the companies behind them - Assess market potential and have access to forecasts till 2010 - Leverage your own technology and brain storm new business opportunities - Investigate mergers, acquisitions and licensing possibilities Drug Eluting Stents - Technology & Market Forecast is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this emerging growth area. Topics Covered 1. Executive Summary 2. State of the Science 2.1 Coronary Artery Disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. (CAD) 2.2 Medical Management 2.3 Coronary Artery Bypass Coronary artery bypass Surgical procedure to reroute blood around a blocked coronary artery. Mentioned in: Heart Failure coronary artery bypass, n & Graft (CABG CABG coronary artery bypass graft. CABG abbr. coronary artery bypass graft CABG Coronary artery bypass graft, see there ) 2.4 Percutaneous Transluminal Coronary Angioplasty percutaneous transluminal coronary angioplasty n. Abbr. PTCA A procedure for enlarging a narrowed arterial lumen by peripheral introduction of a balloon-tip catheter followed by dilation of the lumen as the inflated catheter tip is (PTCA PTCA abbr. percutaneous transluminal coronary angioplasty PTCA Percutaneous transluminal coronary angioplasty, see there ) 2.5 Clinical Trials Update 3. State of the Technology 3.1 Procedure 3.2 Drug Eluting Stents Design & Technology 3.3 Leading Companies & Their Products 3.4 Other Companies in the Space 4. Market Forecast 4.1 The Opportunity 4.2 Market Potential 4.3 Market Forecast List of Tables 1. Drug Eluting Stents - Market Revenue & Growth Rates (2002 - 2005) 2. Drug Eluting Stents - Market Forecasts (2006 - 2010) 3. Clinical Trials Updates (2005) 4. Drug Eluting Stents - Pharmacological Agents 5. Drug Eluting Stents - Products Commercially Available on World Markets 6. Drug Eluting Stents - Products in Development and Near Commercialization 7. Market Potential of Drug Eluting Stents in Coronary Application 8. Drug Eluting Stents - Global Market Segmented by Region (2005) 9. Drug Eluting Stents - Market Shares by Leading Competitor (2005) Companies Mentioned - Abbott - Boston Scientific The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, - Biotronik - Conor Medsystems - Cook Group - Cordis - Johnson & Johnson - Guidant - Medtronic - Sorin Biomedica - Terumo - Translumina - Advanced Bio Prosthetic pros·thet·ic adj. 1. Serving as or relating to a prosthesis. 2. Of or relating to prosthetics. prosthetic serving as a substitute; pertaining to prostheses or to prosthetics. Surfaces - Allvivo - Avantec Vascular - Biocompatibles - Biointerface - Biosensors International - Blue Medical - CardioMind - CardioTech - Devax - Endovasc - Implant Sciences - InnoCore - Lombard Medical - Medical Ventures - Orbus Medical Technologies - Reva Medical - SonoTek - SurModics - X-Cell Medical - Xtent For more information visit http://www.researchandmarkets.com/reports/c36906 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion